Famotidine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Impact of a Histamine H2 Receptor Antagonist (H2RA) on the Pharmacokinetics (PK) of Telaglenastat in Healthy Subjects
Condition:   Drug Interaction Interventions:   Drug: Telaglenastat;   Drug: Famotidine;   Drug: Placebo for famotidine Sponsors:   Calithera Biosciences, Inc;   Novotech (Australia) Pty Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2020 Category: Research Source Type: clinical trials